Repositori institucional URV
Español Català English
TITLE:
Weight management using meal replacements and cardiometabolic risk reduction in individuals with pre-diabetes and features of metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials - imarina:9366331

URV's Author/s:Nishi, Stephanie Kimiko / Salas Salvadó, Jorge
Author, as appears in the article.:Noronha JC; Nishi SK; Khan TA; Blanco Mejia S; Kendall CWC; Kahleová H; Rahelić D; Salas-Salvadó J; Leiter LA; Lean MEJ; Sievenpiper JL
Author's mail:jordi.salas@urv.cat
stephanie.nishi@urv.cat
Author identifier:0000-0003-2700-7459
Journal publication year:2024
Publication Type:Journal Publications
APA:Noronha JC; Nishi SK; Khan TA; Blanco Mejia S; Kendall CWC; Kahleová H; Rahelić D; Salas-Salvadó J; Leiter LA; Lean MEJ; Sievenpiper JL (2024). Weight management using meal replacements and cardiometabolic risk reduction in individuals with pre-diabetes and features of metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials. Obesity Reviews, 25(7), e13751-e13751. DOI: 10.1111/obr.13751
Papper original source:Obesity Reviews. 25 (7): e13751-e13751
Abstract:This review synthesized the evidence from randomized controlled trials comparing the effect of meal replacements (MRs) as part of a weight loss intervention with conventional food-based weight loss diets on cardiometabolic risk in individuals with pre-diabetes and features of metabolic syndrome. MEDLINE, EMBASE, and Cochrane Library were searched through January 16, 2024. Data were pooled using the generic inverse variance method and expressed as mean difference [95% confidence intervals]. The overall certainty of the evidence was assessed using GRADE. Ten trials (n = 1254) met the eligibility criteria. MRs led to greater reductions in body weight (-1.38 kg [-1.81, -0.95]), body mass index (BMI, -0.56 kg/m2 [-0.78, -0.34]), waist circumference (-1.17 cm [-1.93, -0.41]), HbA1c (-0.11% [-0.22, 0.00]), LDL-c (-0.18 mmol/L [-0.28, -0.08]), non-HDL-c (-0.17 mmol/L [-0.33, -0.01]), and systolic blood pressure (-2.22 mmHg [-4.20, -0.23]). The overall certainty of the evidence was low to moderate owing to imprecision and/or inconsistency. The available evidence suggests that incorporating MRs into a weight loss intervention leads to small important reductions in body weight, BMI, LDL-c, non-HDL-c, and systolic blood pressure, and trivial reductions in waist circumference and HbA1c, beyond that seen with conventional food-based weight loss diets.© 2024 The Authors. Obesity Reviews published by John Wiley & Sons Ltd on behalf of World Obesity Federation.
Article's DOI:10.1111/obr.13751
Link to the original source:https://onlinelibrary.wiley.com/doi/10.1111/obr.13751
Papper version:info:eu-repo/semantics/publishedVersion
licence for use:https://creativecommons.org/licenses/by/3.0/es/
Department:Bioquímica i Biotecnologia
Licence document URL:https://repositori.urv.cat/ca/proteccio-de-dades/
Thematic Areas:Ciências ambientais
Ciências biológicas ii
Ciências biológicas iii
Educação física
Endocrinology & metabolism
Endocrinology, diabetes and metabolism
Enfermagem
General medicine
Medicina i
Medicina ii
Medicina iii
Nutrição
Odontología
Public health, environmental and occupational health
Saúde coletiva
Keywords:Meal replacements
Metabolic syndrome
Prediabetes
Weight management
Entity:Universitat Rovira i Virgili
Record's date:2024-06-22
Search your record at:

Available files
FileDescriptionFormat
DocumentPrincipalDocumentPrincipalapplication/pdf

Information

© 2011 Universitat Rovira i Virgili